Search

Your search keyword '"Krempf, Michel"' showing total 675 results

Search Constraints

Start Over You searched for: Author "Krempf, Michel" Remove constraint Author: "Krempf, Michel"
675 results on '"Krempf, Michel"'

Search Results

151. Existe-t-il des biomarqueurs lipidiques prédictifs du diabète de type 2 ? Application sur la cohorte Isphan Cohort Study (ICS)

152. Plasma lipidome characterization using UPLC-ESI-HRMS and ion mobility of hypertriglyceridemic patients on nicotinic acid

153. A relevant glucose-insulin dynamics model for type 1 diabetes

154. [Does a slight overweight increase life expectancy?]

155. A consensus statement on lipid management after acute coronary syndrome

156. Bioavailability of starch and postprandial changes in splanchnic glucose metabolism in pigs

157. Noninvasive tracing of human liver metabolism: comparison of phenylacetate and apoB-100 to sample glutamine

159. Comparison of gas chromatography–mass spectrometry and gas chromatography–combustion–isotope ratio mass spectrometry analysis for in vivo estimates of metabolic fluxes

161. Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody

162. Carotid and femoral atherosclerotic plaques show different morphology.: Patterns of Peripheral Arterial Disease

167. Liraglutide 3.0 mg Reduces Body Weight and Improves Cardiometabolic Risk Factors in Adults with Overweight/Obesity: The SCALE Obesity and Prediabetes Randomised Trial

168. Additional Analyses of the Weight-lowering Efficacy of Liraglutide 3.0 mg in Adults with Overweight and Obesity: The SCALE Obesity and Prediabetes Randomized Trial

169. Liraglutide 3.0 mg Reduces Body Weight and Improves Health-Related Quality of Life (HRQoL) in Overweight or Obese Adults without Diabetes: The SCALE Obesity and Prediabetes Randomized, Double-Blind, Placebo-Controlled, 56-Week Trial

172. Use of advanced cluster analysis to characterize seafood consumption patterns and methylmercury exposures among pregnant women

173. PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia

174. Use of advanced cluster analysis to characterize seafood consumption patterns and methyle mercury exposures among pregnant women

178. Proprotein convertase subtilisin/kexin type 9 (PCSK9) expression is regulated by insulin, sterol regulator element binding protein 1C (SREBP 1c) and the peroxisome proliferator-activated receptor a (PPARa)

179. Fasting induces hyperlipidemia in mice overexpressing PCSK9

180. Proprotein Convertase Subtilisin/Kexin type 9 is repressed by PPARa and its overexpression during fasting results in massive hypertryglyceridemia

181. Proprotein convertase subtilisin/kexin type 9 (PCSK9) expression is regulated by insulin, an its overexpression during fasting results in hyperlipidaemia

183. Childhood obesity and insulin resistance in a Yucatan mini-piglet model : putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development

184. Bioavailability of starch, rate of glucose absorption and intestinal metabolism in pigs

185. Measurement of exogenous acetate production during colonic fermentation of lactulose using (1-13C) acetate in humans

186. Thiazolidinedione use is not associated with worse cardiovascular outcomes: A study in 28,332 high risk patients with diabetes in routine clinical practice

188. Acebutolol and alprenolol metabolism predictions: comparative study of electrochemical and cytochrome P450-catalyzed reactions using liquid chromatography coupled to high-resolution mass spectrometry

191. Voltammetry coupled to mass spectrometry in the presence of isotope 18O labeled water for the prediction of oxidative transformation pathways of activated aromatic ethers: Acebutolol

192. Integration of microbiology and infectious disease teaching courses in an interdisciplinary training programme (Master level) centred on the 'One world, one health' WHO concept.

193. Direct and maternal n-3 long-chain polyunsaturated fatty acid supplementation improved triglyceridemia and glycemia through the regulation of hepatic and muscle sphingolipid synthesis in offspring hamsters fed a high-fat diet.

195. Aliment et santé. Quels glucoses dans les aliments pour garantir notre santé ?

196. Kinetic aspects of acetate metabolism in healthy humans using (1 -13 C) acetate

197. Exploration du métabolisme par les isotopes stables in vivo chez l'homme

198. Low Rate of Production of Apolipoproteins B100 and AI in 2 Patients With Anderson Disease (Chylomicron Retention Disease)

Catalog

Books, media, physical & digital resources